Copyright: ©Author(s) 2026.
World J Gastroenterol. Nov 28, 2026; 32(44): 122876
Published online Nov 28, 2026. doi: 10.3748/wjg.122876
Published online Nov 28, 2026. doi: 10.3748/wjg.122876
Figure 4 Treatment satisfaction of patients at week 2.
FM: Flupentixol-melitracen; LPZ: Lansoprazole; P + LPZ: Lansoprazole plus placebo.
- Citation: Yin KH, Wang XY, Wang XY, Cheng L, Wang B, Wang QQ, Qiao Y, Tang XR, Yan XJ, Chen SL. Efficacy and safety of neuromodulators combined with proton pump inhibitors for non-erosive reflux disease: A randomized clinical trial. World J Gastroenterol 2026; 32(44): 122876
- URL: https://www.wjgnet.com/1007-9327/full/v32/i44/122876.htm
- DOI: https://dx.doi.org/10.3748/wjg.122876